LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 41.11 27.76 2524 3331 0.7576 0.9212
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 42.81 27.76 196 3596 0.0545 0.3212
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 42.81 27.76 3195 3596 0.8884 0.9666
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 42.81 27.76 1047 3596 0.2911 0.6775
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 42.81 27.76 2658 3596 0.7391 0.9157
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 44.52 27.76 208 3884 0.0535 0.3265
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 44.52 27.76 3416 3884 0.8794 0.9643
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 44.52 27.76 1265 3884 0.3257 0.7088
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 44.52 27.76 2848 3884 0.7332 0.9148
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 46.22 27.76 233 4125 0.0565 0.3429
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 46.22 27.76 3599 4125 0.8725 0.9625
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 46.22 27.76 1352 4125 0.3278 0.7135
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 46.22 27.76 3023 4125 0.7329 0.9157
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 47.93 27.76 282 4421 0.0638 0.3729
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 47.93 27.76 3867 4421 0.8746 0.9637
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 47.93 27.76 1494 4421 0.3379 0.7243
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 47.93 27.76 3229 4421 0.7303 0.9159
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 49.63 27.76 307 4818 0.0637 0.3813
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 49.63 27.76 4148 4818 0.8609 0.9601
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 49.63 27.76 1690 4818 0.3508 0.7373
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 49.63 27.76 3440 4818 0.7140 0.9115
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 51.33 27.76 374 5117 0.0731 0.4128
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 51.33 27.76 4362 5117 0.8524 0.9580
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 51.33 27.76 1841 5117 0.3598 0.7460
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 51.33 27.76 3624 5117 0.7082 0.9104
MN20160318_Q01
D12